Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Carmen Lau; Valkal Bhatt; Parastoo B. Dahi; Sean Devlin; Yeon Yoo; Nelly G. Adel; Chris Mazis; Miguel Perales; Sergio A. Giralt; Guenther Koehne; Doris M Ponce; Genovefa A Papanicolaou; Juliet N. Barker

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Carmen Lau, Valkal Bhatt, Parastoo B. Dahi, Sean Devlin, Yeon Yoo, Nelly G. Adel, Chris Mazis, Miguel Perales, Sergio A. Giralt, Guenther Koehne, Doris M Ponce, Genovefa A Papanicolaou, Juliet N. Barker

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Dec 2 2016
Event	Blood - Duration: Jan 1 2020 → …

Conference

Conference	Blood
Period	1/1/20 → …

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Cite this

@conference{731c3304c6af46c7be0267c6d3b5981b,

title = "Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients",

author = "Carmen Lau and Valkal Bhatt and Dahi, \{Parastoo B.\} and Sean Devlin and Yeon Yoo and Adel, \{Nelly G.\} and Chris Mazis and Miguel Perales and Giralt, \{Sergio A.\} and Guenther Koehne and Ponce, \{Doris M\} and Papanicolaou, \{Genovefa A\} and Barker, \{Juliet N.\}",

note = "Introduction: Unrelated donor CB transplantation (CBT) is effective therapy for patients (pts) with high-risk hematologic malignancies without suitable adult donors. CBT, however, can be complicated by CMV infection in seropositive recipients with viremia rates as high as 100\%. Moreover, CMV infection is associated with increased transplant-related mortality (TRM) in some reports.; Blood ; Conference date: 01-01-2020",

year = "2016",

month = dec,

day = "2",

language = "American English",

}

TY - CONF

T1 - Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

AU - Lau, Carmen

AU - Bhatt, Valkal

AU - Dahi, Parastoo B.

AU - Devlin, Sean

AU - Yoo, Yeon

AU - Adel, Nelly G.

AU - Mazis, Chris

AU - Perales, Miguel

AU - Giralt, Sergio A.

AU - Koehne, Guenther

AU - Ponce, Doris M

AU - Papanicolaou, Genovefa A

AU - Barker, Juliet N.

N1 - Introduction: Unrelated donor CB transplantation (CBT) is effective therapy for patients (pts) with high-risk hematologic malignancies without suitable adult donors. CBT, however, can be complicated by CMV infection in seropositive recipients with viremia rates as high as 100%. Moreover, CMV infection is associated with increased transplant-related mortality (TRM) in some reports.

PY - 2016/12/2

Y1 - 2016/12/2

UR - http://www.bloodjournal.org/content/128/22/2219?sso-checked=true

M3 - Presentation

T2 - Blood

Y2 - 1 January 2020

ER -

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Conference

Disciplines

Other files and links

Cite this